Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ValueGene

ValueGene
2005 FOUNDED
M&A STATUS
11-20 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of deoxyribonucleic acid (DNA) synthesis services. The company provides biotech services for gene discovery and specializes in deoxyribonucleic acid (DNA) synthesis and ribonucleic acid (RNA) synthesis for biological research laboratories.

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Primary Office
  • 6342 Ferris Square
  • San Diego, CA 92121
  • United States

+1 (858) 000-0000

ValueGene Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore ValueGene‘s full profile, request access.

Request full access to PitchBook

ValueGene Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SeqLL Corporation Woburn, MA 00 000 00000000 000
000 000000 Venture Capital-Backed Paris, France 000.00 00000000000 000.00
To view this company’s complete list of competitors, request access »

ValueGene Executive Team (1)

Name Title Board
Seat
Contact
Info
Longze Cui President & Chief Executive Officer